Evidence map›Paper›PMID 30886338›Full record

ArticleScientific reports2019

Anti-HIV-1 integrase potency of methylgallate from Alchornea cordifolia using in vitro and in silico approaches.

Xavier Siwe-Noundou, Thommas M Musyoka, Vuyani Moses, Derek T Ndinteh, Dumisani Mnkandhla, Heinrich Hoppe, Özlem Tastan Bishop, Rui W M Krause

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. The GenusMolecules (Basel, Switzerland) · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Cordidepsine is A Potential New Anti-HIV Depsidone fromMolecules (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xavier Siwe-NoundouDepartment of Chemistry, Rhodes University, Grahamstown, 6140, South Africa. xavsiw@gmail.com.ORCID 0000-0002-8667-8351
Thommas M MusyokaResearch Unit in Bioinformatics (RUBi), Department of Biochemistry and Microbiology, Rhodes University, Grahamstown, 6140, South Africa.
Vuyani MosesResearch Unit in Bioinformatics (RUBi), Department of Biochemistry and Microbiology, Rhodes University, Grahamstown, 6140, South Africa.
Derek T NdintehDepartment of Applied Chemistry, University of Johannesburg, Doornfontein, Johannesburg, 2028, South Africa.
Dumisani MnkandhlaDepartment of Biochemistry and Microbiology, Rhodes University, Grahamstown, 6140, South Africa.
Heinrich HoppeDepartment of Biochemistry and Microbiology, Rhodes University, Grahamstown, 6140, South Africa.
Özlem Tastan BishopResearch Unit in Bioinformatics (RUBi), Department of Biochemistry and Microbiology, Rhodes University, Grahamstown, 6140, South Africa. O.TastanBishop@ru.ac.za.ORCID 0000-0001-6861-7849
Rui W M KrauseDepartment of Chemistry, Rhodes University, Grahamstown, 6140, South Africa. r.krause@ru.ac.za.
Rhodes University · ZAUniversity of Johannesburg · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

According to the 2018 report of the United Nations Programme on HIV/AIDS (UNAIDS), acquired immune deficiency syndrome (AIDS), a disease caused by the human immunodeficiency virus (HIV), remains a significant public health problem. The non-existence of a cure or effective vaccine for the disease and the associated emergence of resistant viral strains imply an urgent need for the discovery of novel anti-HIV drug candidates. The current study aimed to identify potential anti-retroviral compounds from Alchornea cordifolia. Bioactive compounds were identified using several chromatographic and spectroscopic techniques and subsequently evaluated for cytotoxicity and anti-HIV properties. Molecular modelling studies against HIV-1 integrase (HIV-1 IN) were performed to decipher the mode of action of methylgallate, the most potent compound (IC

Indexed as

Acquired Immunodeficiency SyndromeDrug Evaluation, PreclinicalEuphorbiaceaeGallic AcidHeLa CellsHIV-1HIV IntegraseHIV Integrase InhibitorsHumansInhibitory Concentration 50Molecular Docking SimulationMolecular Dynamics SimulationPlant BarkPlant StemsProtein DomainsRecombinant ProteinsGallic AcidHIV IntegraseHIV Integrase Inhibitorsmethyl gallatep31 integrase protein, Human immunodeficiency virus 1Recombinant Proteins

Identifiers

PMID30886338
PMCPMC6423119
OpenAlexW2922400944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.